Product Name:

MKK4-pS80


Product Number:

ab-pk716

Price:

Regular price
$89.00
Regular price
Sale price
$89.00

Download Product PDF

Target Full Name: MAPK/ERK protein-serine kinase 4 (MKK4); Dual specificity mitogen-activated protein kinase kinase 4

Target Alias: c-Jun N- terminal kinase kinase 1; C-JUN N-terminal kinase kinase 1; JNK activating kinase 1; JNK kinase 1; JNKK1; Kinase SEK1; MAP2K4; SEK1; SERK1; SAPKK1; SAPKK-1; SKK1; CCDS11162.1; ENSG00000065559

Product Type Specific: Protein kinase phosphosite-specific antibody

Antibody Code: PK716

Antibody Target Type: Phosphosite-specific

Antibody Phosphosite: S80

Protein UniProt: P45985

Protein SigNET: P45985

Antibody Type: Polyclonal

Antibody Host Species: Rabbit

Antibody Immunogen Source: Human MKK4 (MAP2K4, MEK4) sequence peptide Cat. No.: PE-04ANT99

Antibody Immunogen Sequence: RTH(pS)IES(bA)C

Antibody Immunogen Description: Corresponds to amino acid residues R77 to S83; In the N-terminal portion of the kinase before the kinase catalytic domain.

Production Method: Corresponds to amino acid residues R77 to S83; In the N-terminal portion of the kinase before the kinase catalytic domain.

Antibody Modification: Protein kinase phosphosite-specific antibody

Antibody Concentration: 1 mg/ml

Storage Buffer: Phosphate buffered saline pH 7.4, 0.05% Thimerasol

Storage Conditions: For long term storage, keep frozen at -40°C or lower. Stock solution can be kept at +4°C for more than 3 months. Avoid repeated freeze-thaw cycles.

Product Use: Western blotting | Antibody microarray

Antibody Dilution Recommended: 2 µg/ml for immunoblotting

Antibody Potency: Medium immunoreactivity with immunogen peptide on dot blots.

Antibody Species Reactivity: Human

Antibody Positive Control: The observed molecular mass of the processed target protein on SDS-PAGE gels is reported to be around 42-46 kDa.

Scientific Background: MKK4 (MAP2K4, MEK4) is a dual specificity protein kinase of the STE group and STE7 family Phosphorylation of S257 and T261 increases phosphotransferase activity. Phosphorylation of S80 inhibits its phosphotransferase activity. It acts as a critical component in the MAP kinase (MAPK) and the stress-activated protein kinase/c-Jun N-terminal kinase (SAP/JNK) signalling pathways. It has a role in maintaining peripheral lymphoid homeostasis and apoptosis. Mutations and deletions of this genes leads to dysregulated JNK signalling and promotes oncogenesis. MKK4 appears to be a tumour suppressor protein (TSP), but it may also promote metastasis. Cancer-related mutations in human tumours point to a loss of function of the protein kinase. The active form of the protein kinase normally acts to inhibit tumour cell proliferation. However, significantly elevated expression of MKK4 has been observed in invasive pancreatic cancer specimens, indicating a possible role for the protein in tumourigenesis. MKK4 over-expression is correlated with increased expression of heat shock protein 27 (HSP27) and matrix metalloproteinase 2 (MMP-2) protein, which are required for the increased invasive phenotype of the cells. Therefore, MKK4 appears to have an important role in the promotion of metastasis in pancreatic cancer cells. Insertional mutagenesis studies in mice support a role for this protein kinase in mouse cancer oncogenesis.